Clinical Trials in Baltimore

Showing 21941-21960 of 23,476 trials

A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)

NCT00683930

This study was designed to assess the efficacy and safety of CellCept (1 g or 1.5 g orally twice daily for 52 weeks) in patients with pemphigus vulgaris receiving prednisone or other corticosteroids. During the study, patients had their corticosteroid dose gradually reduced if they responded to treatment. The anticipated time on study treatment was 12 months, and the target sample size was \<100 individuals.

Pemphigus Vulgaris (PV)

Hoffmann-La Roche96 participantsStarted May 2004

Los Angeles, California, United States • Atlanta, Georgia, United States • Baltimore, Maryland, United States +23 more locations

COMPLETEDPhase 3< 1 mile

An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)

NCT00465088

To demonstrate that niacin ER and simvastatin (NS) tablets, when compared to atorvastatin (Lipitor®; Pfizer, Inc.), has superior high-density lipoprotein cholesterol (HDL-C) elevating effects at Week 12 in subjects with type II hyperlipidemia or mixed dyslipidemia who are currently off lipid-modifying therapy. This was a prospective, randomized, open-label, blinded endpoint (PROBE) study.

HyperlipidemiaMixed Dyslipidemia

Abbott199 participantsStarted Apr 2007

Anaheim, California, United States • Huntington Park, California, United States • Long Beach, California, United States +43 more locations

A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)

An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)

Find Trials by Condition in Baltimore

Effects of Manualized Treatment in a Seamless System

Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial

Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus

A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache

Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2)

OP Device vs. Bone Autograft for the Treatment of Tibial Nonunions

Hematuria Evaluation Trial for Subjects With Microscopic or Gross Hematuria to Determine the Absence or Presence of Bladder Cancer

Evaluation of the Accuracy of the INRatio Prothrombin Time (PT) Monitoring System With a New Test Strip for the Oral Anticoagulation Therapy Patient in the Presence of Heparin and Low Molecular Weight Heparin (e.g., Enoxaparin or Dalteparin)

Intranasal Civamide for Episodic Cluster Headache

A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea

Palliative Care Study in Patients With Advanced Cancer

Safety and Efficacy of T Cell Genetic Immunotherapy for HIV

Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder

DPBRN Reasons for Replacement or Repair of Dental Restorations

DPBRN Blood Sugar Testing in Dental Patients

Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma

Electrophysiologic and Morphologic Assessment of the Substrate to Guide Implantation of Defibrillators in Dilated Cardiomyopathy